Carlos Echevarria Selected Research

Biomarkers (Surrogate Marker)

11/2023

Admission blood eosinophil count, inpatient death and death at 1 year in exacerbating patients with COPD.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carlos Echevarria Research Topics

Disease

7	Chronic Obstructive Pulmonary Disease (COPD) 03/2024 - 10/2018
2	Cystic Fibrosis (Mucoviscidosis) 01/2022 - 03/2015
2	Lung Diseases (Lung Disease) 01/2022 - 03/2015
1	Coma (Comas) 11/2023
1	Gastroesophageal Reflux (GERD) 01/2022
1	Respiratory Insufficiency (Respiratory Failure) 10/2020
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 10/2020
1	Persistent Infection 03/2015
1	Dizziness (Lightheadedness) 03/2015
1	Inflammation (Inflammations) 03/2015
1	Yellow Nail Syndrome 10/2014
1	Pleural Effusion (Pleural Effusions) 10/2014
1	Yellow Fever 02/2005

Drug/Important Bio-Agent (IBA)

3	Oxygen (Dioxygen)IBA 03/2021 - 10/2019
1	Urea (Carbamide)FDA LinkGeneric 11/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2023
1	Biomarkers (Surrogate Marker)IBA 11/2023
1	AlbuminsIBA 11/2023
1	C-Reactive ProteinIBA 11/2023
1	elexacaftorIBA 01/2022
1	ivacaftor drug combination tezacaftorIBA 01/2022
1	Carbon DioxideIBA 03/2021
1	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 03/2015
1	SaltsIBA 03/2015
1	ivacaftorIBA 03/2015
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 10/2014
1	VaccinesIBA 02/2005

Therapy/Procedure

3	Therapeutics 03/2021 - 03/2015
2	Drug Therapy (Chemotherapy) 03/2024 - 01/2020
1	Nebulizers and Vaporizers (Inhaler) 03/2024
1	Noninvasive Ventilation 10/2020
1	Patient Transfer (Patient Dumping) 01/2020